Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality at home could help MS patients regain hand control

NCT ID NCT07193602

Symptom relief Sponsor: Christian Kamm Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a home-based virtual reality (VR) headset program can improve manual dexterity in people with multiple sclerosis (MS). Sixty participants with MS who have trouble with hand function will be randomly assigned to either the VR dexterity training or a sham meditation program. The main goal is to see if the VR training reduces difficulty with hand tasks, as measured by a questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality headset-based dexterity training program
What this could lead to
If it works, this could offer a convenient, home-based way to improve hand function and quality of life for people with multiple sclerosis.
What could go wrong
This is a small, early-stage trial with only 60 participants. The sham group uses a meditation program, which may not be a perfect comparison. Results may not apply to all MS types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria (Thompson et al. 2017) * Age between 18 and 75 years * Written informed consent signed by the subject must be obtained prior to study start * Patient must complain about MS related impaired manual dexterity negatively affecting ADL and/or QoL * Patients must have Arm function in multiple sclerosis questionnaire (AMSQ) score \>41 Exclusion Criteria: * A relapse that started within 60 days prior to screening * Rapidly progressive disease * Any disease/condition that impaired manual dexterity besides MS * Any disease other than MS that could possibly explain the patient's signs and symptoms * Medical or psychiatric conditions that compromise the ability to comply with the protocol, or to complete the study * History of epilepsy or epileptic seizures * A history of drug abuse in the 12 months prior to screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Lucerne Cantonal Hospital

    Lucerne, Canton of Lucerne, 6000, Switzerland

  • MS Centre, Neurology, University hospital Basel

    Basel, Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.